$50,000 of TAKEDA PHARMACEUTICALS AMERICA INC. lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Tax reform in 2025."
You can find more data on corporate lobbying on Quiver Quantitative.
TAK Hedge Fund Activity
We have seen 155 institutional investors add shares of TAK stock to their portfolio, and 127 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ADAGE CAPITAL PARTNERS GP, L.L.C. added 3,433,023 shares (+inf%) to their portfolio in Q1 2025, for an estimated $51,049,052
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 2,815,917 shares (-66.8%) from their portfolio in Q1 2025, for an estimated $41,872,685
- MILLENNIUM MANAGEMENT LLC removed 1,754,246 shares (-87.7%) from their portfolio in Q1 2025, for an estimated $26,085,638
- SOLEUS CAPITAL MANAGEMENT, L.P. removed 1,180,000 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $17,546,600
- GOLDMAN SACHS GROUP INC added 692,404 shares (+15.0%) to their portfolio in Q1 2025, for an estimated $10,296,047
- CAUSEWAY CAPITAL MANAGEMENT LLC removed 522,030 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $7,762,586
- BNP PARIBAS FINANCIAL MARKETS removed 500,001 shares (-99.9%) from their portfolio in Q1 2025, for an estimated $7,435,014
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
